Our study presents a spectrum of pathogenic and likely pathogenic germline variants of the TP53 gene in a large cohort of Russian patients diagnosed with various cancers, along with clinical characteristics and family oncological history of carrier patients. The gene discussed is TP53; the disease is cancer.